Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia STEM News.
Press releases published on September 4, 2025
September 4, 2025
iManage Reports Strong ANZ Growth as Firms Embrace Cloud and AI
Indeterminate
GlobeNewswire
September 4, 2025
Myriad Genetics Announces Precise MRD Clinical Data Published in The Lancet Oncology
Indeterminate
GlobeNewswire
September 4, 2025
XRP News: Sparkvia AI Public Sale is Open — Why SPARK Token Is The Must-Have Utility Token on XRP
Indeterminate
GlobeNewswire
September 4, 2025
Don’t Miss AI Utility on XRP — Sparkvia (SPK) Token Public Sale Now Live
Indeterminate
GlobeNewswire
September 4, 2025
Live! Casinos Expand Their Use of the QCI Enterprise Platform
Indeterminate
GlobeNewswire
September 4, 2025
Charting New Zealand's $76B AI Future: Enlighten Designs to Honour Top Innovators at Aotearoa AI Summit
Indeterminate
GlobeNewswire
September 4, 2025
Cerence AI Files Patent Infringement Suit Against Apple
Indeterminate
GlobeNewswire
September 4, 2025
Computer Modelling Group Announces Voting Results of Election of Directors and New Board Chair
Indeterminate
GlobeNewswire
September 4, 2025
ADARx Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Indeterminate
GlobeNewswire
September 4, 2025
Surrozen Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
September 4, 2025
Microchip Technology to Present at the Goldman Sachs Communacopia + Technology Conference
Indeterminate
GlobeNewswire
September 4, 2025
Lifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing Conference
Indeterminate
GlobeNewswire
September 4, 2025
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire
September 4, 2025
Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
Indeterminate
GlobeNewswire
September 4, 2025
Praxis Precision Medicines to Participate in September Investor Conferences
Indeterminate
GlobeNewswire
September 4, 2025
Indaptus Therapeutics Provides Clinical Update
Indeterminate
GlobeNewswire
September 4, 2025
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre
Indeterminate
GlobeNewswire